Laparoscopic spleen-preserving distal pancreatectomy for pancreatic neoplasms: A retrospective study

Table 1 Patient demographics n (%)

Variable	Data
No. of patients	38
Gender (Male/Female)	9 (23.7)/29 (76.3)
Mean age (yr)	53.2 ± 13.6
ASA classification (I/II)	26 (68.4)/12 (31.6)
BMI (kg/m2)	24.4 ± 2.7
Comorbidities	12 (31.6)
Diabetes mellitus	6 (15.7)
Hypertension	3 (7.9)
Cardiovascular	2 (5.3)
Pulmonary	2 (5.3)
Liver	1 (2.6)
Others	1 (2.6)

ASA: American Society of Anesthesiologists classification; BMI: Body mass index.

Table 2 Histological analysis

Histological diagnosis	n	Mean size (cm)
Pancreatic retention cyst	2	5.0
Pancreatic epithelial cyst	5	5.2
Congenital cyst of pancreas	1	4.8
Insulinoma	1	3.8
Serous cystadenoma	13	3.9
Mucinous cystadenoma	10	3.1
Pancreatic solid-pseudopapillary tumors	4	3.0
Well-differentiated neuroendocrine tumor	1	2.1
Intraductal papillary mucinous tumor	1	2.3
Total	38	4.5

Table 3 Intra-operative features of patients undergoing laparoscopic spleen-preserving distal pancreatectomy n (%)

	LSPDP (n = 38)
Surgical technique
Splenic vessels preservation (Kimura’s method)	36 (94.7)
Splenic vessels resection (Warshaw’s method)	2 (5.3)
Operative time (min)	123.2 ± 52.4
Estimated blood loss (mL)	78.2 ± 39.5
Transfusion (cases)	1 (2.6)

LSPDP: Laparoscopic spleen-preserving distal pancreatectomy.

Table 4 Post-operative features of patients undergoing laparoscopic spleen-preserving distal pancreatectomy n (%)

	LSPDP (n = 38)
Total complications	7 (18.4)
Grade I	5 (13.2)
Grade II	2 (5.3)
Grade IIIa/IIIb	0 (0)/0 (0)
Details of complications
Pancreatic fistula	5 (13.2)
Grade A	3 (7.9)
Grade B	2 (5.3)
Grade C	0 (0.0)
Pneumonia	1 (2.6)
Intra-abdominal abscess	1 (2.6)
Time to activities (d)	1.5 ± 0.6
Time to first flatus (d)	2.2 ± 1.0
Time to starting liquid (d)	2.8 ± 0.9
Time to starting soft diets (d)	4.0 ± 1.2
Postoperative hospital stay (d)	7.6 ± 2.9
30-d mortality	0 (0.0)

LSPDP: Laparoscopic spleen-preserving distal pancreatectomy.